Safety study of two new drugs in healthy men
Part of Kidney & urinary clinical trials.
This study tests two new experimental drugs (AD-116 and AD-1161) in healthy adult men to see how safe they are and how the body processes them. If you are a healthy man who meets the weight and age criteria, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a healthy man age 19 or older
- Weigh at least 110 pounds (50 kilograms)
- Have a body mass index (BMI) between 18 and 30
- Not have taken part in another drug study in the last 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if two different versions of the study drug AD-116A work the same way in the body. It only includes healthy adult men, so it's not a treatment for a specific disease but helps confirm the drug's safety and absorption.
This trial compares two versions of a medicine (AD-116A and AD-1161) to see if they work the same in the body when taken after eating. It is for healthy adult men to help ensure the new version is as good as the original.
This trial tests how two study drugs, AD-2321 and AD-2322, interact with each other in the body and checks if they are safe for healthy adults. Taking part will help researchers learn more about these drugs for future use.
This study tests two new drugs in healthy adults to see how safe they are and how the body processes them. Taking part may help researchers learn if the drugs are safe for future use, though there is no direct benefit to you.
This trial tests two forms of a new medicine to see how safe they are and how the body handles them. It is for healthy adults aged 19 to 64, and participation helps gather important early information before the drug is studied in patients.
This trial tests how three study drugs interact with each other in healthy adults. It may help find safe doses for future treatments.
Hear when a new Benign Prostatic Hyperplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.